158 related articles for article (PubMed ID: 9643585)
21. Activation of MeIQ (2-amino-3,4-dimethylimidazo- [4,5-f]quinoline) by sequence variants of recombinant human cytochrome P450 1A2.
Josephy PD; Bibeau KL; Evans DH
Environ Mol Mutagen; 2000; 35(4):328-35. PubMed ID: 10861951
[TBL] [Abstract][Full Text] [Related]
22. Cytochrome P450 expression system for high-throughput real-time detection of genotoxicity: Application to the study of human CYP1A2 variants.
Palma BB; Moutinho D; Urban P; Rueff J; Kranendonk M
Mutat Res Genet Toxicol Environ Mutagen; 2016 Aug; 806():24-33. PubMed ID: 27476332
[TBL] [Abstract][Full Text] [Related]
23. Stable expression of human CYP1A2 and N-acetyltransferases in Chinese hamster CHL cells: mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
Yanagawa Y; Sawada M; Deguchi T; Gonzalez FJ; Kamataki T
Cancer Res; 1994 Jul; 54(13):3422-7. PubMed ID: 8012961
[TBL] [Abstract][Full Text] [Related]
24. Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocyclic amines.
Suzuki A; Kushida H; Iwata H; Watanabe M; Nohmi T; Fujita K; Gonzalez FJ; Kamataki T
Cancer Res; 1998 May; 58(9):1833-8. PubMed ID: 9581821
[TBL] [Abstract][Full Text] [Related]
25. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450-mediated biotransformation (a corrigendum report on Duarte et al. (2005) Mutagenesis 20, 93-100).
Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
Mutagenesis; 2007 Jan; 22(1):75-81. PubMed ID: 17158518
[TBL] [Abstract][Full Text] [Related]
26. Nitrogen-substitution effects on the mutagenicity and cytochrome P450 isoform-selectivity of chrysene analogs.
Yamada K; Hakura A; Kato TA; Mizutani T; Saeki K
Mutat Res; 2005 Sep; 586(1):87-95. PubMed ID: 16087391
[TBL] [Abstract][Full Text] [Related]
27. Plasmid-mediated expression of the UmuDC mutagenesis proteins in an Escherichia coli strain engineered for human cytochrome P450 1A2-catalyzed activation of aromatic amines.
Josephy PD; Evans DH; Williamson V; Henry T; Guengerich FP
Mutat Res; 1999 Oct; 429(2):199-208. PubMed ID: 10526205
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin.
Takahashi E; Fujita K; Kamataki T; Arimoto-Kobayashi S; Okamoto K; Negishi T
Mutat Res; 2002 Oct; 508(1-2):147-56. PubMed ID: 12379470
[TBL] [Abstract][Full Text] [Related]
29. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
30. In vitro mutagenicity of selected environmental carcinogens and their metabolites in MutaMouse FE1 lung epithelial cells.
Hölzl-Armstrong L; Nævisdal A; Cox JA; Long AS; Chepelev NL; Phillips DH; White PA; Arlt VM
Mutagenesis; 2020 Dec; 35(6):453-463. PubMed ID: 33399867
[TBL] [Abstract][Full Text] [Related]
31. Recombinant human P450 forms 1A1, 1A2, and 1B1 catalyze the bioactivation of heterocyclic amine mutagens in Escherichia coli lacZ strains.
Josephy PD; Batty SM; Boverhof DR
Environ Mol Mutagen; 2001; 38(1):12-8. PubMed ID: 11473383
[TBL] [Abstract][Full Text] [Related]
32. Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo[4, 5-f]quinoline, mediated by cDNA-expressed human CYP1A2.
Miranda CL; Yang YH; Henderson MC; Stevens JF; Santana-Rios G; Deinzer ML; Buhler DR
Drug Metab Dispos; 2000 Nov; 28(11):1297-302. PubMed ID: 11038156
[TBL] [Abstract][Full Text] [Related]
33. Genotoxicity of aflatoxin B1: evidence for a recombination-mediated mechanism in Saccharomyces cerevisiae.
Sengstag C; Weibel B; Fasullo M
Cancer Res; 1996 Dec; 56(23):5457-65. PubMed ID: 8968101
[TBL] [Abstract][Full Text] [Related]
34. Activation of aminophenylnorharman, aminomethylphenylnorharman and aminophenylharman to genotoxic metabolites by human N-acetyltransferases and cytochrome P450 enzymes expressed in Salmonella typhimurium umu tester strains.
Oda Y; Totsuka Y; Wakabayashi K; Guengerich FP; Shimada T
Mutagenesis; 2006 Nov; 21(6):411-6. PubMed ID: 17067997
[TBL] [Abstract][Full Text] [Related]
35. Non-coplanar and coplanar polychlorinated biphenyls potentiate genotoxicity of aflatoxin B1 in a human hepatocyte line by enhancing CYP1A2 and CYP3A4 expression.
Chen Y; Liu Y
Environ Pollut; 2019 Mar; 246():945-954. PubMed ID: 31159144
[TBL] [Abstract][Full Text] [Related]
36. Genotoxicity assessment of aromatic amines and amides in genetically engineered V79 cells.
Rodrigues AS; Silva ID; Caria MH; Laires A; Chaveca T; Glatt HR; Rueff J
Mutat Res; 1994 Dec; 341(2):93-100. PubMed ID: 7527492
[TBL] [Abstract][Full Text] [Related]
37. Short-term black tea intake modulates the excretion of urinary mutagens in rats treated with 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ): role of CYP1A2 upregulation.
Yoxall VR; Parker DA; Kentish PA; Ioannides C
Arch Toxicol; 2004 Aug; 78(8):477-82. PubMed ID: 15034640
[TBL] [Abstract][Full Text] [Related]
38. Expression, purification, and characterization of a catalytically active human cytochrome P450 1A2:rat NADPH-cytochrome P450 reductase fusion protein.
Parikh A; Guengerich FP
Protein Expr Purif; 1997 Apr; 9(3):346-54. PubMed ID: 9126606
[TBL] [Abstract][Full Text] [Related]
39. Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human.
Edwards RJ; Murray BP; Murray S; Schulz T; Neubert D; Gant TW; Thorgeirsson SS; Boobis AR; Davies DS
Carcinogenesis; 1994 May; 15(5):829-36. PubMed ID: 8200083
[TBL] [Abstract][Full Text] [Related]
40. Biphasic effects of the flavonoids quercetin and naringenin on the metabolic activation of 2-amino-3,5-dimethylimidazo[4,5-f]quinoline by Salmonella typhimurium TA1538 co-expressing human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and cytochrome b5.
Kang IH; Kim HJ; Oh H; Park YI; Dong MS
Mutat Res; 2004 Jan; 545(1-2):37-47. PubMed ID: 14698415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]